Stryker Corporation - Asset Resilience Ratio
Stryker Corporation (SYK) has an Asset Resilience Ratio of 0.18% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See SYK working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1998–2025)
This chart shows how Stryker Corporation's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Stryker Corporation balance sheet assets.
Liquid Assets Composition Over Time
This chart breaks down Stryker Corporation's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore Stryker Corporation (SYK) long-term investment share to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $85.00 Million | 0.18% |
| Total Liquid Assets | $85.00 Million | 0.18% |
Asset Resilience Insights
- Limited Liquidity: Stryker Corporation maintains only 0.18% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Stryker Corporation Industry Peers by Asset Resilience Ratio
Compare Stryker Corporation's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for Stryker Corporation (1998–2025)
The table below shows the annual Asset Resilience Ratio data for Stryker Corporation.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 8.57% | $4.10 Billion | $47.84 Billion | -1.67pp |
| 2024-12-31 | 10.24% | $4.40 Billion | $42.97 Billion | +2.59pp |
| 2023-12-31 | 7.65% | $3.05 Billion | $39.91 Billion | +2.42pp |
| 2022-12-31 | 5.23% | $1.93 Billion | $36.88 Billion | -3.49pp |
| 2021-12-31 | 8.72% | $3.02 Billion | $34.63 Billion | -0.09pp |
| 2020-12-31 | 8.81% | $3.02 Billion | $34.33 Billion | -5.86pp |
| 2019-12-31 | 14.67% | $4.42 Billion | $30.17 Billion | +1.08pp |
| 2018-12-31 | 13.58% | $3.70 Billion | $27.23 Billion | +0.99pp |
| 2017-12-31 | 12.59% | $2.79 Billion | $22.18 Billion | -3.97pp |
| 2016-12-31 | 16.56% | $3.38 Billion | $20.43 Billion | +12.25pp |
| 2015-12-31 | 4.31% | $700.00 Million | $16.25 Billion | -13.79pp |
| 2014-12-31 | 18.09% | $3.21 Billion | $17.71 Billion | +1.32pp |
| 2013-12-31 | 16.78% | $2.64 Billion | $15.74 Billion | -4.68pp |
| 2012-12-31 | 21.46% | $2.89 Billion | $13.47 Billion | +1.20pp |
| 2011-12-31 | 20.26% | $2.51 Billion | $12.40 Billion | -3.81pp |
| 2010-12-31 | 24.07% | $2.62 Billion | $10.90 Billion | -1.24pp |
| 2009-12-31 | 25.31% | $2.30 Billion | $9.07 Billion | +5.66pp |
| 2008-12-31 | 19.66% | $1.49 Billion | $7.60 Billion | -9.18pp |
| 2007-12-31 | 28.83% | $2.12 Billion | $7.35 Billion | +11.84pp |
| 2006-12-31 | 16.99% | $998.20 Million | $5.87 Billion | +5.56pp |
| 2005-12-31 | 11.43% | $565.30 Million | $4.94 Billion | +11.30pp |
| 1999-12-31 | 0.14% | $3.50 Million | $2.58 Billion | -0.46pp |
| 1998-12-31 | 0.60% | $17.26 Million | $2.89 Billion | -- |
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment … Read more